Management of lichen sclerosus with triamcinolone ointment: Effectiveness in reduction of patient symptom scores

Journal of Lower Genital Tract Disease

Volumn 15, Issue 3, 2011, Pages 205-209

  Lefevre, Cherie ^a   Hoffstetter, Susan ^a   Meyer, Sara ^a   Gavard, Jeffery ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lichen sclerosus; triamcinolone ointment; vulvar pruritus

Indexed keywords

TRIAMCINOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DYSPAREUNIA; FEMALE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; RATING SCALE; SYMPTOM; VULVA BURNING; VULVA DISEASE; VULVA PAIN; VULVA PRURITUS;

ADULT; DYSPAREUNIA; FEMALE; GENITAL DISEASES, FEMALE; GLUCOCORTICOIDS; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; MISSOURI; OINTMENTS; PRURITUS VULVAE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE;

EID: 79959925436     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31820a3b6f     Document Type: Article

References (6)

1. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol 2005;48:808Y17.
2. Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerousus in a general gynecology practice. J Reprod Med 2005;50:477Y80.
3. Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004;140:702Y6.
4. Ayhan A, Guven S, Guvendag Guven ES, Sakinci M, Gultekin M, Kucukali T. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynaecol Obstet 2007; 96:117Y21.
5. Gilbertson EO, Spellman MC, Piacquadio DJ, Mulford MI. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998;38(2 Pt 2):318Y21.
6. Staughton RC, August PJ. Cushings syndrome and pituitary-adrenal suppression due to clobetasol propionate. Br Med J 1975;24:419Y21.